Market

Annual Results

You can view the Annual Results for the last 5 years.

ANNUAL RESULTS

GlaxoSmithKline Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 55936.18 P/BV 33.44 Book Value ( ₹ ) 98.74
52 Week High/Low ( ₹ ) 3516/1921 FV/ML 10/1 P/E(X) 60.13
Book Closure 30/05/2025 EPS ( ₹ ) 54.91 Div Yield (%) 1.64
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Net Sales/Income from operations3749.213453.713251.723278.033198.86
Total Income From Operations3749.213453.713251.723278.033198.86
      
EXPENDITURE     
Consumption of Raw Materials499.90545.17427.48611.18472.02
Purchase of Traded Goods845.11853.08788.43729.44880.11
Increase/Decrease in Stocks45.85-63.7268.9615.57-39.43
Employees Cost579.70624.39594.99610.23614.69
Depreciation66.7969.6865.7768.1979.28
Other Expenses601.29586.10567.57549.73576.14
Total Expenses2638.642614.702513.202584.342582.81
      
P/L Before Other Inc. , Int., Excpt. Items & Tax1110.57839.01738.52693.69616.05
Other Income145.93122.59100.6675.78110.58
P/L Before Interest, Excpt. Items & Tax1256.50961.60839.18769.47726.63
Interest1.311.801.812.003.53
P/L Before Exceptional Items & Tax1255.19959.80837.37767.47723.10
Exceptional Items4.69-143.61-0.9711.58-172.60
P/L Before Tax1259.88816.19836.40779.05550.50
Tax332.30226.23228.76398.28192.35
P/L After Tax from Ordinary Activities927.58589.96607.64380.77358.15
Extra Ordinary Item0.000.003.051313.950.00
Net Profit/Loss For the Period927.58589.96610.691694.72358.15
Net P/L After Minority Interest & Share Of Associates927.58589.96610.691694.72358.15
      
Equity Share Capital169.41169.41169.41169.41169.41
Reserves And Surplus1781.901617.241573.542493.551308.85
EPS Before Extra Ordinary *     
Basic EPS (Rs.)54.5241.1436.08100.0421.14
Diluted EPS (Rs.)54.7634.8336.08100.0421.14
EPS After Extra Ordinary *     
Basic EPS (Rs.) 54.5241.1436.05100.0421.14
Diluted EPS (Rs.) 54.7634.8336.05100.0421.14
      
PBITOE Margin (%)29.6224.2922.7121.1619.25
PBTE Margin (%)33.4727.7925.7523.4122.60
PBT Margin (%)33.6023.6325.7223.7617.20
PAT Margin (%)24.7417.0818.7851.6911.19
PAT After MI And SOA Margin (%)24.7417.0818.7851.6911.19
ParticularsMar 25
Net Sales/Income from operations3749.21
Total Income From Operations3749.21
  
EXPENDITURE 
Consumption of Raw Materials499.90
Purchase of Traded Goods845.11
Increase/Decrease in Stocks45.85
Employees Cost579.70
Depreciation66.79
Other Expenses601.29
Total Expenses2638.64
P/L Before Other Inc. , Int., Excpt. Items & Tax1110.57
Other Income145.93
P/L Before Interest, Excpt. Items & Tax1256.50
Interest1.31
P/L Before Exceptional Items & Tax1255.19
Exceptional Items4.69
P/L Before Tax1259.88
Tax332.30
P/L After Tax from Ordinary Activities927.58
Extra Ordinary Item0.00
Net Profit/Loss For the Period927.58
Net P/L After Minority Interest & Share Of Associates927.58
Equity Share Capital169.41
Reserves And Surplus1781.90
EPS Before Extra Ordinary * 
Basic EPS (Rs.)54.52
Diluted EPS (Rs.)54.76
EPS After Extra Ordinary * 
Basic EPS (Rs.) 54.52
Diluted EPS (Rs.) 54.76
PBITOE Margin (%)29.62
PBTE Margin (%)33.47
PBT Margin (%)33.60
PAT Margin (%)24.74
PAT After MI And SOA Margin (%)24.74